New Evidence in RA and AS: Biologic Registries & What they are Telling Us – MOC Section 1

Upon completion of this program, participants will be able to:

1. Identify ways to apply biologics patient registry data to everyday clinical practice in RA and AS
2. Better understand new observational evidence in RA and AS
3. Gain insight into the timing of biologic initiation
4. Feel more confident choosing between anti-TNF therapies in the long-term management of RA and AS